Surprising in a way that some of the giants in order to satisfy their growth appetite’s have not moved in, or perhaps the carrier pigeons have been shuttling offers over and since the company “can’t comment on the contents of any carrier pigeon messages” we the little people can only wait for news. BMY’s growth profited enormously from Celgene’s portfolio. If they need some protein to go with that high carb diet, even out the sugar highs and lows, Leronlimab would be a fantastic platform drug to fuel their Artemis rocket ambitions.

Maybe there is a pigeon message coming our way December 7th…I’m looking more realistically to 2023 but am hopeful something is in flight.